CD180 and ischemia: Building on this work, it was shown that CD180 overexpression can ameliorate cardiomyocyte apoptosis via inhibition of TLR4 signaling and p38MAPK phosphorylation signalin ischemia/reperfusion injury rat models (Li et al. 2016; Yang et al. 2015).